Miami, FL, United States of America

James N Kenealy

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 117(Granted Patents)


Company Filing History:


Years Active: 1997-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: James N Kenealy: Innovator in Transdermal Drug Delivery

Introduction

James N Kenealy is a notable inventor based in Miami, FL (US). He has made significant contributions to the field of pharmacology, particularly in the area of transdermal drug delivery systems. With a total of 3 patents to his name, Kenealy's work focuses on improving patient compliance and minimizing side effects in drug administration.

Latest Patents

Kenealy's latest patents include a method and device for the transdermal administration of azapirones. This innovative approach allows for the delivery of therapeutically effective doses of the drug azospirone to treat psychogenic symptomatologies. One embodiment of his invention comprises an effective amount of solubilized azospirone in a transdermal drug delivery device. By utilizing this method, constant blood concentrations of azospirone can be maintained over a prolonged period, enhancing patient compliance while minimizing side effects.

Career Highlights

Throughout his career, Kenealy has demonstrated a commitment to advancing medical technology. His work has not only contributed to the scientific community but has also provided practical solutions for patients requiring effective treatment options.

Collaborations

Kenealy has collaborated with various professionals in the field, including his coworker Cheryl M Gentile. Their combined expertise has furthered the development of innovative drug delivery systems.

Conclusion

James N Kenealy's contributions to transdermal drug delivery represent a significant advancement in medical technology. His innovative methods aim to improve patient outcomes and compliance, showcasing the importance of continued research and development in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…